Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Accounts Payables (2020 - 2024)

Historic Accounts Payables for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $2.3 million.

  • Mainz Biomed's Accounts Payables fell 2792.77% to $2.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.3 million, marking a year-over-year decrease of 2792.77%. This contributed to the annual value of $2.3 million for FY2024, which is 2792.77% down from last year.
  • Per Mainz Biomed's latest filing, its Accounts Payables stood at $2.3 million for Q4 2024, which was down 2792.77% from $3.2 million recorded in Q4 2023.
  • Over the past 5 years, Mainz Biomed's Accounts Payables peaked at $3.2 million during Q4 2023, and registered a low of $399137.0 during Q4 2020.
  • Moreover, its 5-year median value for Accounts Payables was $2.3 million (2024), whereas its average is $1.9 million.
  • In the last 5 years, Mainz Biomed's Accounts Payables soared by 24624.33% in 2022 and then tumbled by 2792.77% in 2024.
  • Over the past 5 years, Mainz Biomed's Accounts Payables (Quarter) stood at $399137.0 in 2020, then soared by 96.62% to $784786.0 in 2021, then soared by 246.24% to $2.7 million in 2022, then increased by 17.19% to $3.2 million in 2023, then fell by 27.93% to $2.3 million in 2024.
  • Its Accounts Payables stands at $2.3 million for Q4 2024, versus $3.2 million for Q4 2023 and $2.7 million for Q4 2022.